Skip to main content
Caplight Logo









Ligence

Ligence

Private
KaunasHealthcare & Life Scienceshttps://ligence.io/

Last Round

Grant

Feb 13, 2026

Total Funding Raised

$3.74M

Momentum

Top 25%

of companies Caplight tracks

Company Overview

Ligence is a health-tech company that provides an AI-powered software platform to automate the analysis and reporting of heart ultrasound images.

Sector

Healthcare & Life Sciences

Verticals

Medical Imaging, Medical AI, Healthcare Analytics, Computer Vision

Business Model

B2B

Customer Profile

Subscription SaaS, Services & Consulting

AI Layer

Application

Keywords

echocardiography AIAI echoautomated echo analysisSoftware as a Medical DeviceSaMDmedical imaging AIcardiology AIcardiac reporting softwareglobal longitudinal strainLV GLSTTE analysisPACS integrationFDA clearanceCE mark softwareEHR integrationmedical computer vision

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

Ligence Comparables

Compare Ligence with similar companies based on industry and business-model similarity.

Ligence comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
Us2.ai
89%
AISAP
87%
InVision Medical Technology
86%

Ligence Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
GrantFeb 13, 2026
SeedNov 12, 2024
GrantOct 29, 2020
Pre SeedAug 18, 2020

Key People

Founding team and executive leadership

Arnas Karužas

Chief Executive Officer

Executive Team

Dmitrij Abolichin

Chief Technology Officer

Executive Team

Dovydas Matuliauskas

CFO & Business Development Manager, Business Development Manager

Executive Team

Justinas Balčiūnas

Chief Operating Officer

Executive Team

Ligence Investors

Notable investors and investment history

Market signals

Structured signals derived from secondary market and firmographic data.

  • Aug 21, 2026

    Monthly visitors grew 128% MoM, from 382 to 872.

  • Feb 13, 2026

    $55K grant received from the European Union.

Ligence Filings

Explore SEC and related filing metadata, where available.

Ligence filings preview — column headings only; records require access
TypeDateAmount OfferedAmount SoldFilingPagesDownload

Filing documents are not displayed on this public page. Request access to learn about available coverage.

Request access

Frequently Asked Questions

Common questions about Ligence's valuation, stock price, and market status.

Is Ligence a public or private company?

Ligence is a private company.

What is the current stock price of Ligence?

Ligence is a private company with no public stock price. No recent secondary market data is available.

How much is Ligence worth (valuation)?

Valuation information for Ligence is not publicly available.

Can I buy Ligence stock?

Ligence shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.

When was Ligence's last funding round?

Ligence's most recent funding round was Grant on February 13, 2026.

Who are the main investors in Ligence?

Key investors in Ligence include Simpact Ventures.

Will Ligence IPO soon?

No public IPO plans have been announced for Ligence.

How can I track Ligence secondary market activity?

Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor Ligence's secondary market activity and sign up for updates.

Firmographic Details

HeadquartersKaunas
Employee Range25
Year Founded2019
Last FundingFeb 13, 2026

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.

See something wrong or outdated?